Biggest News Aggregation in the World
📰 Early Access Program News

Page 42 - Early Access Program News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Early Access Program. Real-time updates on events, politics, business and more.

Merus N.V.: Merus Presents Clinical Data on Zenocutuzumab in NRG1-fusion (NRG1+) Cancers at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting (Oral Abstract)

- 61 patients with NRG1+ cancer have been enrolled, including 45 patients evaluable for response as of the April 13, 2021 data cutoff date- Encouraging early clinical activity observed, with confirmed
United Kingdom Andrew Joe Alison Schram Exchange Commission Early Access Program Company Conference Call

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Square Announces Integrated Omnichannel Solutions For Businesses Makes Debut in Ireland

Square Announces Integrated Omnichannel Solutions For Businesses Makes Debut in Ireland   Payment company Square Inc (NYSE:SQ) announced on Tuesday it has launched its integrated omnichannel solutions for businesses in Ireland. The fintech giant reported that following what it calls a successful Early Access Program, now all merchants and enterprises throughout the country may access Square’s “innovative ecosystem” with tools they need to start, run, grow, and adapt their businesses. �...
Alyssa Henry Square Inc Early Access Program Team Management Executive Vice President Extends Square

Android Automotive and Auto are still separate things, but soon making apps for them won't be

Google is making a change to Android Auto apps that should have been there in the first place Google is moving to unify app development for Android Auto and Android Automotive. It feels long overdue, as theres no good reason to have two different routes for creating apps for what is essentially the same form factor. Not too long ago, Google introduced a Cars App Library as part of Jetpack for EV charging and parking apps for Android Auto, and its now making this package available for Android Au...
Cars App Library Early Access Program Android Auto Android Automotive கார்கள் செயலி நூலகம் ஆரம்ப நுழைவு ப்ரோக்ர்யாம்

Merus Announces Financial Results for the First Quarter and

MCLA-145 clinical update planned for 2H21  MCLA-129 first patient dosed in phase 1/2 trial  Cecile Geuijen, Ph.D., promoted to Chief Scientific Officer UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 06, 2021 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we”, or “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics ® and Triclonics ®), today announced financial results for the first qua...
United Kingdom United States Zenocutuzumab Zeno Cecile Geuijen American Association For Cancer Research American Society Of Clinical Oncology

Tesla privately admits Elon Musk has been exaggerating about 'full self-driving'

Tesla privately admits Elon Musk has been exaggerating about ‘full self-driving’ Share this story Photo by Britta Pedersen-Pool/Getty Images Tesla CEO Elon Musk has been overstating the capabilities of the company’s advanced driver assist system, the company’s director of Autopilot software told the California Department of Motor Vehicles. The comments came from a memo released by legal transparency group PlainSite, which obtained the documents from a public records request. It was the...
United States Dal Prescott Elon Musk Eric Williams Miguel Acosta California Department Of Motor Vehicles

Merus N.V.: Merus Announces Financial Results for the First Quarter and Provides Business Update

Merus N.V.: Merus Announces Financial Results for the First Quarter and Provides Business Update MCLA-145 clinical update planned for 2H21 MCLA-129 first patient dosed in phase 1/2 trial Cecile Geuijen, Ph.D., promoted to Chief Scientific Officer UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 06, 2021 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) ("Merus", the "Company," "we", or "our"), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Bicloni...
United Kingdom United States Bruxelles Capitale Zenocutuzumab Zeno Cecile Geuijen Eli Lilly

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science